Linefor

Pregabalin, the active ingredient in Linefor, is a gabapentinoid presented as an oral tablet for oral use. It is indicated for neuropathic pain, epilepsy and anxiety disorders in adult patients. GNH USA supplies Linefor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pregabalin acts on the nervous system to relieve several chronic pain and seizure conditions. - Diabetic peripheral neuropathic pain: reduces pain intensity and improves functional ability. - Postherpetic neuralgia: alleviates lingering nerve pain after shingles. - Fibromyalgia: lessens widespread musculoskeletal pain and fatigue. - Partial onset seizures: decreases frequency of focal seizures. - Generalized anxiety disorder: diminishes anxiety symptoms and improves daily functioning.

Pregabalin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower extremities. - Weight gain: gradual increase in body weight. - Dry mouth: reduced salivation. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Angioedema: rapid swelling of face, lips, tongue, or throat. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Respiratory depression: slowed breathing, especially with CNS depressants. - Anaphylaxis: acute allergic reaction with hives, difficulty breathing. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Renal impairment: adjust dose according to creatinine clearance. - Suicidal ideation: monitor mood changes and emergent thoughts of self‑harm. - Abrupt discontinuation: taper gradually to avoid withdrawal symptoms. - Elderly patients: start at lower dose and increase cautiously. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Pregabalin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression and sedation. - Central nervous system depressants (e.g., benzodiazepines, alcohol): increase risk of severe drowsiness and impaired coordination.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may enhance hypoglycaemic effect; monitor blood glucose. - NSAIDs: may increase risk of peripheral edema. - Diuretics: can raise pregabalin plasma concentrations; observe for toxicity.